Dear Shareholders:
As an independent director of Yunnan Baiyao Group Co., Ltd. (hereinafter referred to as "the Company") during the 10th Board of Directors, I strictly adhered to the Company Law, Securities Law, Corporate Governance Guidelines for Listed Companies, Management Measures for Independent Directors of Listed Companies, and other relevant laws and regulations, as well as the Company's Articles of Association and the Independent Director Annual Report Work System. I have acted in good faith, loyalty, and diligence, maintaining the independence of my role and safeguarding the legitimate rights and interests of the Company and all shareholders, especially minority shareholders. The Company completed the re-election of the 11th Board of Directors on November 10, 2025, and I hereby report on my performance during the 2025 term as follows:
1. Meeting Attendance
In 2025, the 10th Board of Directors held a total of 7 meetings, and I attended all 7 meetings in accordance with relevant regulations, with no absences or instances of failing to attend two consecutive meetings. The Company also held 3 shareholder meetings, and I attended all 2 meetings required during my term. The specific attendance details are shown in the table below:
| Meeting Type | Total Required Attendance | In-Person Attendance | Attendance by Communication | Proxy Attendance | Absences | Consecutive Absences | Shareholder Meetings Attendance |
|---|---|---|---|---|---|---|---|
| Board Meetings | 7 | 2 | 5 | 0 | 0 | No | 2 |
I believe that during the reporting period, the convening, content, and procedures of all Board and shareholder meetings complied with laws, regulations, and the Company's Articles of Association. Before each meeting, I received and thoroughly understood the relevant materials in advance, actively participated in discussions, and made reasonable suggestions. After the meetings, I continued to monitor the implementation of resolutions and exercised my rights as an independent director to contribute positively to the Board's scientific decision-making. Throughout the reporting period, I voted in favor of all proposals reviewed at the Board meetings, with no opposing or abstaining votes.